Concepedia

Sarah Gunningham

SG

Statistics

Publications

12

Citations

921

H-Index

12

Active since

2000

Affiliations

University of Otago(Current)

University of Oxford

Christchurch Hospital

John Radcliffe Hospital

Canterbury District Health Board

Sarah Gunningham is an author at University of Otago specializing in medicine, oncology, and molecular oncology.

Publications per year

2000–2013

12

Publications

12

The angiogenic switch for vascular endothelial growth factor (VEGF)‐A, VEGF‐B, VEGF‐C, and VEGF‐D in the adenoma–carcinoma sequence during colorectal cancer progression

Vickie Hanrahan, Margaret J. Currie, Sarah Gunningham et al. · The Journal of Pathology · 2003 · 237 citations · Full text

, , +17

Modulation of hypoxia-inducible factor-1 alpha in cultured primary cells by intracellular ascorbate

Margret C.M. Vissers, Sarah Gunningham, Mary J. Morrison et al. · Free Radical Biology and Medicine · 2006 · 130 citations

, , +16

The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers.

Sarah Gunningham, Margaret J. Currie, Bridget A. Robinson et al. · PubMed · 2000 · 108 citations

, , +17

Expression of the angiopoietins and their receptor Tie2 in human renal clear cell carcinomas; regulation by the von Hippel‐Lindau gene and hypoxia

Margaret J. Currie, Sarah Gunningham, Kevin Turner et al. · The Journal of Pathology · 2002 · 88 citations

, , +17

Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity

Margaret J. Currie, Brooke Beardsley, Gavin Harris et al. · Human Pathology · 2012 · 76 citations

, , +17

1–5 of 12